Editing Essential thrombocythemia (section)

==Pregnancy==
[[Hydroxycarbamide]] and [[anagrelide]] are contraindicated during [[pregnancy]] and [[nursing]].<ref name="preg" /> Essential thrombocythemia can be linked with a three-fold increase in risk of [[miscarriage]].<ref name="emerg" /> Throughout pregnancy, close monitoring of the mother and [[fetus]] is recommended.<ref name="preg" /> Low-dose [[low molecular weight heparin]] (e.g. [[enoxaparin]]) may be used.<ref name="preg" /> For life-threatening complications, the platelet count can be reduced rapidly using [[plateletpheresis]], a procedure that removes platelets from the blood and returns the remainder to the patient.<ref name="preg">{{cite journal |last1=Valera |first1=MC |last2=Parant |first2=O |last3=Vayssiere |first3=C |last4=Arnal |first4=JF |last5=Payrastre |first5=B |title=Essential thrombocythemia and pregnancy |journal=European Journal of Obstetrics, Gynecology, and Reproductive Biology |date=October 2011 |volume=158 |issue=2 |pages=141–7 |doi=10.1016/j.ejogrb.2011.04.040 |pmid=21640467}}</ref>